The prognostic role of a novel TP53 mutation classifier in resectable esophageal squamous-cell carcinoma

被引：1
|
作者：
Su, Dan [1 ]
Huang, Minran [1 ]
Jin, Jiaoyue [1 ]
Wu, Yingxue [1 ]
Ying, Lisa [1 ]
Zhang, Fanrong [1 ]
Chen, Kaiyan [1 ]
机构：
[1] Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e14749
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14749
引用
收藏
页数：1
相关论文
共 50 条
  • [41] The Prognostic Value of TP53 Alteration in Patients with Head and Neck Squamous Cell Carcinoma Receiving Immunotherapy
    Jiang, Chao
    Zhou, Xuanchen
    Han, Jie
    Yue, Zhiyong
    Li, Butuo
    ONCOLOGIST, 2022, 27 (07): : E604 - E605
  • [42] ESOPHAGEAL SQUAMOUS-CELL CARCINOMA
    SERRA, LB
    BRITISH JOURNAL OF SURGERY, 1981, 68 (04) : 292 - 292
  • [43] PROGNOSTIC VALUE OF HISTOPATHOLOGIC PARAMETERS OF ESOPHAGEAL SQUAMOUS-CELL CARCINOMA
    SARBIA, M
    BITTINGER, F
    PORSCHEN, R
    DUTKOWSKI, P
    WILLERS, R
    GABBERT, HE
    CANCER, 1995, 76 (06) : 922 - 927
  • [44] PROGNOSTIC AND THERAPEUTIC ROLE OF TP53 MUTATIONS IN MEDULLOBLASTOMA SUBGROUPS; THERAPEUTIC ROLE OF LITHIUM IN ABROGATION OF TP53 MUTATION ASSOCIATED RADIATION RESISTANCE
    Zhukova, Nataliya
    Martin, Dianna
    Lipman, Tatiana
    Castelo-Branco, Pedro
    Zhang, Cindy
    Fraser, Michael
    Baskin, Berivan
    Ray, Peter
    Bouffet, Eric
    Alman, Benjamin
    Ramaswamy, Vijay
    Dirks, Peter
    Clifford, Steven
    Rutkowski, Stefan
    Pfister, Stefan
    Taylor, Michael
    Malkin, David
    Hawkins, Cynthia
    Tabori, Uri
    PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 992 - 992
  • [45] Tumorigenic Role of Podoplanin in Esophageal Squamous-Cell Carcinoma
    Rahadiani, Nur
    Ikeda, Jun-ichiro
    Makino, Tomoki
    Tian, Tian
    Qiu, Ying
    Mamat, Suhana
    Wang, Yi
    Doki, Yuichiro
    Aozasa, Katsuyuki
    Morii, Eiichi
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (05) : 1311 - 1323
  • [46] Tumorigenic Role of Podoplanin in Esophageal Squamous-Cell Carcinoma
    Nur Rahadiani
    Jun-ichiro Ikeda
    Tomoki Makino
    Tian Tian
    Ying Qiu
    Suhana Mamat
    Yi Wang
    Yuichiro Doki
    Katsuyuki Aozasa
    Eiichi Morii
    Annals of Surgical Oncology, 2010, 17 : 1311 - 1323
  • [47] A NOVEL PROGNOSTIC INDEX IN PATIENTS WITH RESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA: FIBRINOGEN/PREALBUMIN RATIO
    Feng, Ji-Feng
    Wang, Liang
    Jiang, You-Hua
    Yang, Xun
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2020, 72 (01): : 46 - 54
  • [48] MUTATION SPECTRUM OF TP53 GENE IN ESOPHAGEAL CARCINOMA WITH HIGH AMOUNT OF FUSOBACTERIUM SPECIES
    Tahara, Tomomitsu
    Shijimaya, Takuya
    Yamazaki, Jumpei
    Matsumoto, Yasushi
    Nakamura, Naohiro
    Takahashi, Yu
    Tomiyama, Takashi
    Fukui, Toshiro
    Naganuma, Makoto
    GASTROENTEROLOGY, 2024, 166 (05) : S1170 - S1170
  • [49] miR612 is associated with esophageal squamous cell carcinoma development and metastasis, mediated through TP53
    Zhou, Ping
    Dong, He
    He, Shuqian
    Fang, Lei
    Jiang, Nan
    Sun, Qing
    MOLECULAR MEDICINE REPORTS, 2017, 16 (02) : 1855 - 1863
  • [50] ESOPHAGEAL SQUAMOUS-CELL PAPILLOMA, SUSPECTED OF SQUAMOUS-CELL CARCINOMA
    YUKI, T
    KAWANO, S
    OGIHARA, T
    SATO, N
    OKAMOTO, S
    SATO, K
    KAMADA, T
    TAKADA, N
    FURUKAWA, J
    OKAMURA, J
    INTERNAL MEDICINE, 1993, 32 (10) : 773 - 776
12345